Biotech

Vivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, is betting that the future of AI-driven medicine hinges on a simple but elusive resource: high-quality data from living human tissue. The company, which has raised just under $80 million from investors led by Khosla Ventures, last week opened what it calls […]